FSLY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Fastly Inc (FSLY) is not a strong buy for a beginner investor with a long-term focus at this time. While the company has shown revenue growth and improving gross margins, its net income and EPS have significantly declined. The lack of strong proprietary trading signals, neutral insider and hedge fund activity, and mixed analyst sentiment suggest waiting for more clarity on the company's financial trajectory and market performance before investing.
The technical indicators show a bullish trend with moving averages (SMA_5 > SMA_20 > SMA_200) and a positive MACD histogram of 0.281. However, the RSI is at 69.692, nearing overbought territory. The stock is trading above its pivot level of 19.079, with resistance levels at 21.119 and 22.379. Short-term stock trend analysis predicts a slight decline in the next day (-0.84%) and week (-1.78%).
Revenue growth of 22.79% YoY in Q4
Gross margin improvement to 61.39%, up 14.96% YoY.
Analyst upgrades and increased price targets, with RBC Capital raising its target to $20 and William Blair upgrading to Outperform.
Positive sentiment around agentic AI traffic and larger customer deals.
Net income dropped by -52.85% YoY, and EPS declined by -56.52% YoY.
CTO's recent sale of 40,000 shares, which may raise concerns about insider confidence.
No significant hedge fund or insider trading trends.
Stock trend analysis predicts a short-term decline in price.
Lack of proprietary trading signals from AI Stock Picker and SwingMax.
In Q4 2025, Fastly reported revenue growth of 22.79% YoY to $172.6 million. However, net income dropped by -52.85% YoY to -$15.5 million, and EPS declined by -56.52% YoY to -$0.1. Gross margin improved to 61.39%, up 14.96% YoY, indicating better cost management.
Analyst sentiment is mixed. RBC Capital raised its price target to $20 and highlighted improving execution, while William Blair upgraded the stock to Outperform, citing growth in agentic AI traffic. However, other firms like Citi and Piper Sandler maintain Neutral ratings, and some analysts have expressed concerns about price compression and operating losses.
